ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $15.72M in the quarter ending June 30, 2025, with 3,043.40% growth. This brings the company's revenue in the last twelve months to $112.34M, up 22,367.80% year-over-year. In the year 2024, ARS Pharmaceuticals had annual revenue of $89.15M with 297,063.33% growth.

• Revenue (ttm): $112.34M
• Revenue Growth: +22,367.80%
• P/S Ratio: 8.18
• Revenue / Employee: $702,119
• Employees: 160
• Market Cap: 964.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	89.15M	89.12M	297,063.33%
Dec 31, 2023	30.00K	-1.29M	-97.72%
Dec 31, 2022	1.32M	-4.19M	-76.10%
Dec 31, 2021	5.51M	-12.33M	-69.13%
Dec 31, 2020	17.84M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.